ALTEA: A Software Tool for the Evaluation of New Biomarkers for Alzheimer’s Disease by Means of Textures Analysis on Magnetic Resonance Images

The current criteria for diagnosing Alzheimer’s disease (AD) require the presence of relevant cognitive deficits, so the underlying neuropathological damage is important by the time the diagnosis is made. Therefore, the evaluation of new biomarkers to detect AD in its early stages has become one of...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gómez, Carlos, Ortiz-Ramón, Rafael, Mollá-Olmos, Enrique, Moratal, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164667/
https://www.ncbi.nlm.nih.gov/pubmed/30029524
http://dx.doi.org/10.3390/diagnostics8030047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164667/
https://www.ncbi.nlm.nih.gov/pubmed/30029524
http://dx.doi.org/10.3390/diagnostics8030047

Ejemplares similares